Basic Information
OWP Pharmaceuticals Provides FDA-Approved Brand Generic Epilepsy Medications to Patients in the U.S. at Affordable Prices. OWP Pharmaceuticals has established a business model with a significant connection to an organization named ROW Foundation, a "non-profit" entity. Through this model, both organizations share a vision of significantly improving the lives of epilepsy patients worldwide, including underserved patients outside the U.S., by enhancing education, diagnosis, and treatment.
OWP Pharmaceuticals, Inc.
--
less than 15 people
January 01, 2014
--
Enterprise Profile
Industrial Sector
Concept
Application Scenarios

